Dear Reader, An obscure AI stock could crush Nvidia starting Wednesday. And I’m giving you the full details here, for free, in my latest video bulletin. Bottom line: The Federal Reserve is expected to announce a potentially massive interest-rate cut on September 18th — at 2 pm ET. That could unleash a flood of money on Wall Street. And that could — in turn — send demand for this AI stock soaring as major institutions come piling in by the billions. Last time there was an opportunity like this… You could’ve seen 4,000% gains — and counting. Then, I used my Quantum Edge algorithm to scan more than 6,000 possible stocks. It pinpointed... Nvidia, before the big run-up! Now, Nvidia’s run-up has hit some headwinds in recent months. But here’s the good news. My Quantum Edge system just identified an even more promising — still obscure — AI stock. And I firmly believe it will crush Nvidia starting this Wednesday, September 18th, at 2 pm ET. That’s when the Federal Reserve is expected to finally slash interest rates in the U.S. And that — in turn — could unleash another major runup for AI stocks. So why do I think the company revealed here could crush Nvidia after the Fed’s next announcement? That’s what you’ll discover in my latest video bulletin — down to the ticker — for free. (I give you the recommendation and ticker in the second half of the video.) Fair warning: You’ve only got a few days to get in for maximum potential gains. I suggest you move now. Sincerely, 
Jason Bodner
Quantitative Investment Analyst, TradeSmith
P.S. This company could crush Nvidia starting THIS WEDNESDAY. And I’ve confirmed it using the same strategy that has shown my dad as much as 40X gains and counting*… on Nvidia. Again, go here for all the details — including the ticker — for free. It’s all part of my latest project to help regular folks beat Wall Street at their own game. *The investment results described in these testimonials are not typical. Investing in securities carries a high degree of risk; you may lose some or all of the investment. | 
Tidak ada komentar:
Posting Komentar